Maxim Upgrades Gilead Sciences to Buy What This Could Mean for Investors March Core Inflation Hits 32 as Q1 GDP Growth Slows to 2 Geopolitical Tensions Add Pressure on Federal Reserve Accenture and HUMAIN Forge Strategic Partnership to Boost AI Adoption in Saudi Arabia Loop Capital Initiates Coverage on American Express with Buy Rating Designates Stock as Top Pick AMD Commits Over 10 Billion to Taiwan AI Chip Infrastructure Expansion China Industrial Profits Surge 247 in April Fastest Gain in Over Two Years MCHP Q1 2026 Earnings EPS Beats Estimates by 106 as Stock Rises VRTS Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly PFS Q1 2026 Earnings Strong Earnings Beat Amidst Stable Operations JELD Q1 2026 Earnings Significant EPS Miss as Company Faces Headwinds Seaport Entertainment Group Q1 2026 Earnings EPS Misses Estimates Amid Operational Development Griffon Corporation GFF Q1 2026 Earnings EPS Beats Estimates Stock Gains Ground Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295 Columbus Acquisition Corp Rights COLAR Surge 1176 Whats Driving the Recent Rally Brookfield Asset Management BAM Gains 142 Testing Key Resistance Levels Tri Pointe Homes Inc TPH Holds Steady Near 47 as Housing Sector Consolidates Click Holdings Limited CLIK Surges Nearly 10 Amid Improved Market Sentiment Wall Street Divided on Paramount Skydance Outlook Amid Industry Uncertainty Century Communities Q1 2026 Earnings EPS Surges 68 Above Estimates Shares Edge Lower JStar Holding YMAT Faces Selling Pressure as Shares Test Key Support Level QuidelOrtho Q1 2026 Earnings EPS Misses Estimates by Wide Margin Yet Stock Rises BABA Q1 2026 Earnings Massive EPS Miss Shakes Investor Confidence VRTS Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly SILA Q4 2025 Earnings EPS Misses Estimates Despite Positive Stock Movement HOLX Q1 2026 Earnings EPS Falls Short of Expectations by 645 BTE Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment